Pricing Log in Create free account

Azora Therapeutics, Inc. (AZR) vs Passage Bio, Inc. (PASG)

Azora Therapeutics, Inc. and Passage Bio, Inc. are both Biotechnology companies. Passage Bio, Inc. is the larger, with a market value of $11.1M against $9.7M — 1.1× the size. Across the 8 metrics below, Azora Therapeutics, Inc. leads on 6 and Passage Bio, Inc. on 2.

Valuation

Metric AZR PASG Biotechnology median
P/E n/m n/m 10.26
P/S n/m n/m 9.18
P/B n/m 2.48 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.19 0.34 0.65
EV/Sales n/m n/m 8.98
Earnings yield (433.06%) (329.07%) (34.89%)
Free cash flow yield (62.39%) (330.47%) (24.52%)

Profitability

Metric AZR PASG Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 352.60% (169.09%) (50.12%)
Return on assets (322.10%) (69.20%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AZR PASG Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) 82.46% 32.94% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AZR PASG Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.63 1.22 4.89
Net debt to EBITDA 0.75 0.96 1.01

Dividend

Metric AZR PASG Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AZR PASG Biotechnology median
Market cap 9.74m 11.13m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack